Artificial Intelligence (AI) is increasingly being used by biopharma companies to streamline the drug discovery process. AI algorithms can analyse and recognise patterns and trends in data sets from trials and studies at a faster rate than researchers, allowing hypotheses and drug discoveries to come about at expedited rates.
Increasing competition from outside technology companies, who are developing their own healthcare initiatives, has led to a rise in partnerships between tech and Life Science brands. These partnerships provide the Life Science companies with access to broader external expertise and technology not previously available.
Social media platforms are utilised by pharmaceutical companies to stimulate interest and enrolment in clinical trials, with a surge in geo-targeting and social media marketing to reach subjects and patients in a specific area or radius in order to recruit and spread awareness.
At fdu we understand the pace and depth of change in the Life Sciences sector, helping businesses innovate and excel in this exciting environment.